Global Positive Expiratory Pressure (PEP) Devices Market

Report ID : 1276 | Published : 2022-07-04 | Pages: | Format:

The Global Positive Expiratory Pressure (PEP) Devices market is estimated to reach over USD 1.89 billion by 2030, exhibiting a CAGR of 8.0% during the forecast period. 

Positive expiratory pressure therapy (PEP) is performed for airway clearance therapy. A participant in this therapy breathes through a portable mouthpiece or mask. This allows air to pass past the mucus in the lungs and away from the airway walls. The device facilitates unrestricted air passage and requires active inhaled air expiration against resistance. The growth in COPD prevalence due to increased smoking and drinking in industrialized countries, as well as the recent introductions of innovative oscillatory PEP, are pushing the positive expiratory pressure devices market. The rising frequency of chronic pulmonary disorders and technological developments drive market expansion. The PEP devices market is growing due to an ageing population and an increase in chronic disease occurrences.

However, in low-income countries, a lack of awareness regarding technologically advanced airway clearing medicines is projected to stymie the worldwide Positive Expiratory Pressure Devices market growth. Furthermore, the market is expected to advance due to the time-consuming old airway clearance techniques.

Market Segmentation:

The Positive Expiratory Pressure (PEP) Devices market is segmented on the basis of Product, Forms and Sales channels. By product, the market is segmented as Probiotics, Prebiotics, Enzymes and Other Products. The forms segment includes Capsules, Tablets, Liquid and Other Forms. On the basis of sales channel, the market is categorized into Modern Trade, Convenience Stores, Specialty Stores, Multi-brand Stores, Online Retailing and Other Sales Channels.

Based on product type, the high-pressure PEP (26-102cm H2O) segment is accounted as a significant contributor to the Positive Expiratory Pressure (PEP) Devices market.

The global PEP devices market can be divided into two product types: high-pressure PEP (26-102cm H2O) and low-pressure PEP (5-20cm H2O). The high-pressure PEP category earned the most revenue, owing to increased patient compliance with high-pressure devices and increased bronchodilation achieved by pressures more significant than 26 cm H2O. The enhanced patient initiatives to shorten hospital stays are expected to grow the high-pressure PEP segment. PEP devices with high pressure are used to give high levels of positive expiratory pressure (PEP) to the lungs. These devices are commonly utilized in individuals suffering from the chronic obstructive pulmonary disease (COPD), asthma, or other respiratory disorders requiring improved airway clearance. High-pressure PEP devices can be mechanical or electrical, and they can generate the appropriate level of PEP through various processes. Some high-pressure PEPs can be modified to meet the needs of the patient's breathing by turning a knob on the device known as an expiratory resistance control valve, or ERV.

The COPD segment witnessed growth at a rapid rate.

The market will be led by chronic obstructive pulmonary disease (COPD). COPD is caused by an obstruction in the airways, causing difficulty breathing, and is primarily caused by tobacco smoking. According to a 2019 WHO (World Health Organization) report, the chronic obstructive pulmonary disease is the third leading cause of death worldwide. Growing patient awareness for the creation of a shared platform for COPD sufferers is likely to boost the segment's growth during the forecast period.

In the region, the North America Positive Expiratory Pressure (PEP) Devices market holds a significant revenue share.

North America dominates the positive expiratory pressure (PEP) market because of the increasing patient awareness in the region. Some of the factors driving the oscillatory positive expiratory pressure (OPEP) market during the forecast period include the rising prevalence of chronic obstructive pulmonary disease (COPD), increasing technological advancements, rising prevalence of asthma, and continuous technological and research development. The increasing frequency of chronic illnesses, on the other hand, will create several opportunities, resulting in the rise of the positive expiratory pressure (PEP) market within the time period stated. Due to an expanding patient pool and raised spending on healthcare infrastructure development by developing countries, the Asia-Pacific region is projected to expand during the projected period.

Competitive Landscape

The key players in the Positive Expiratory Pressure (PEP) Devices market have shifted their focus towards forming significant approaches such as mergers, investments, and joint ventures of main and domestic players to enhance product portfolios & strengthen their market footprint across the globe. Some of the major key players in the Positive Expiratory Pressure (PEP) Devices market are Smiths Medical, Inc. (ICU Medical), Philips Respironics, Monaghan Medical Corporation, R. Cegla GmbH & Co. KG, PARI GmbH, AirPhysio, Medica Holdings, LLC, DR Burton Healthcare and SoloPep.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Positive Expiratory Pressure (PEP) Devices Market Snapshot

Chapter 4. Global Positive Expiratory Pressure (PEP) Devices Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Market Dynamics - Drivers

4.3. Challenges/Restraints

4.4. Market Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2018 & 2028

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2018 to 2028 for the following Product Type:

5.2.1. High Pressure PEP (26-102cm H2O) Devices

5.2.2. Low Pressure PEP (5-20cm H2O) Devices

Chapter 6. Positive Expiratory Pressure (PEP) Devices Market Segmentation 2: Application Estimates & Trend Analysis

6.1. Application Analysis & Market Share, 2018 & 2028

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2018 to 2028 for the following Application:

6.2.1. Chronic Obstructive Pulmonary Disease (COPD)

6.2.2. Asthma

6.2.3. Atelectasis

6.2.4. Bronchitis

6.2.5. Bronchiectasis

6.2.6. Cystic Fibrosis

6.2.7. Others

Chapter 7. Positive Expiratory Pressure (PEP) Devices Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.1.2. North America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.1.3. North America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2018-2028

7.1.3.1. U.S.

7.1.3.2. Canada

7.2. Europe

7.2.1. Europe Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.2.2. Europe Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.2.3. Europe Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2018-2028

7.2.3.1. Germany

7.2.3.2. Poland

7.2.3.3. France

7.2.3.4. Italy

7.2.3.5. Spain

7.2.3.6. UK

7.2.3.7. Rest of Europe

7.3. Asia Pacific

7.3.1. Asia Pacific Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.3.2. Asia Pacific Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.3.3. Asia Pacific Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) by country, 2018-2028

7.3.3.1. China

7.3.3.2. India

7.3.3.3. Japan

7.3.3.4. Australia

7.3.3.5. Rest of Asia Pacific

7.4. Latin America

7.4.1. Latin America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.4.2. Latin America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.4.3. Latin America Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2018-2028

7.4.3.1. Brazil

7.4.3.2. Rest of Latin America

7.5. MEA

7.5.1. MEA Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2018-2028

7.5.2. MEA Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2018-2028

7.5.3. MEA revenue Positive Expiratory Pressure (PEP) Devices Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2018-2028

7.5.3.1. South Africa

7.5.3.2. Rest of MEA

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Smiths Medical (ICU Medical)

8.2.1.1. Company Overview

8.2.1.2. Financials

8.2.1.3. Product portfolio

8.2.1.4. Business strategy & Recent developments

8.2.2. Philips Respironics

8.2.3. Monaghan Medical Corporation

8.2.4. R. Cegla GmbH & Co. KG

8.2.5. PARI GmbH

8.2.6. AirPhysio

8.2.7. Medica Holdings, LLC

8.2.8. DR Burton Healthcare

8.2.9. SoloPep

8.3. List of Other Prominent Players

Segmentation of Positive Expiratory Pressure (PEP) Devices Market-

By Product Type

  • High Pressure PEP (26-102cm H2O) Devices
  • Low Pressure PEP (5-20cm H2O) Devices

By Application

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Asthma
  • Atelectasis
  • Bronchitis
  • Bronchiectasis
  • Cystic Fibrosis
  • Others

By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa

Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

Need Complete Report ?

Frequently Asked Questions

Who are the Key Players in the Positive Expiratory Pressure (PEP) Devices Market?

USD 1.89 billion by 2030

exhibiting a CAGR of 8.0% during the forecast period.

Our Clients